Taken together, these results demonstrate that the negative regulation of the Rac1 activity by GLS2 is crucial for GLS2 to inhibit the migration and invasion of cancer cells, and furthermore, this function of GLS2 requires the C-terminus of GLS2 and is independent of the glutaminase activity of GLS2. The gene discussed is RAC1; the disease is cancer.